Valuation: Guided Therapeutics Inc

Market Cap 2.62Cr 2.29Cr 2.13Cr 1.96Cr 3.69Cr 252.7Cr 3.74Cr 25Cr 9.93Cr 123.65Cr 9.83Cr 9.62Cr 427.16Cr P/E 2024
-3x
P/E 2025 -12.7x
Enterprise Value 2.91Cr 2.55Cr 2.36Cr 2.17Cr 4.09Cr 280.46Cr 4.15Cr 28Cr 11Cr 137.23Cr 11Cr 11Cr 474.07Cr EV / Sales 2024
1,649x
EV / Sales 2025 64.4x
Free-Float
63.48%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer 70 06/03/2023
Chief Tech/Sci/R&D Officer 70 02/12/2010
Director TitleAgeSince
Director/Board Member 70 01/12/2016
Director/Board Member 76 10/04/2006
Chairman 67 01/10/2013
Change 5-day change 1-year change 3-year change Capi.($)
+0.57%-1.65%+23.11%-7.88% 19TCr
+0.06%-10.79%-5.68%-30.57% 13TCr
-2.68%-12.41%-33.33%+5.29% 12TCr
-0.51%-0.16%-58.35%-17.63% 6.42TCr
-0.21%-3.32%+10.58%-7.69% 4.87TCr
+0.17%+0.82%-24.52%-32.66% 4.38TCr
+0.45%-0.93%+14.86%+4.49% 3.75TCr
+0.89%-1.09%+29.00%+29.22% 3.61TCr
-0.86%+1.99%+87.07%+1.49% 2.91TCr
Average -0.29%-3.08%+4.75%-6.22% 7.82TCr
Weighted average by Cap. -0.42%-3.83%-0.73%-9.09%

Financials

2024 2025
Net sales 7T 6.13T 5.69T 5.23T 9.86T 7L 10T 67.83T 26.55T 3L 26.28T 25.71T 11.42L 8L 7L 6L 6L 10.8L 7.4Cr 10.96L 74.32L 29.09L 3.62Cr 28.79L 28.17L 13Cr
Net income -24.17L -21.18L -19.66L -18.07L -34.04L -23Cr -34.54L -2.34Cr -91.67L -11Cr -90.73L -88.78L -39Cr -31.96L -28L -26L -23.89L -45.01L -31Cr -45.68L -3.1Cr -1.21Cr -15Cr -1.2Cr -1.17Cr -52Cr
Net Debt 17.71L 15.52L 14.41L 13.24L 24.94L 17Cr 25.31L 1.72Cr 67.17L 8.36Cr 66.48L 65.05L 29Cr 28.76L 25.2L 23.39L 21.5L 40.51L 28Cr 41.1L 2.79Cr 1.09Cr 14Cr 1.08Cr 1.06Cr 47Cr
Logo Guided Therapeutics Inc
Guided Therapeutics, Inc. is a medical technology company. The Company is focused on developing medical devices that have the potential to improve healthcare. The Company’s primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device. The underlying technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. LuViva is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point of care by scanning the cervix with light, then analyzing the reflected and fluorescent light. LuViva is designed to provide a less invasive and painless alternative to conventional tests for cervical cancer screening and detection. Additionally, LuViva is designed to improve patient well-being not only because it eliminates pain, but also because it is convenient to use and provides rapid results at the point of care.
Employees
-